Ofer Park - Brosh building - 4th floor
94 Shlomo Shmeltzer Road - POB 3158
+972 3 5773880
Wavelength is a customer-focused world-class developer and manufacturer of Active Pharmaceutical Ingredients (APIs)
It is the independent company of choice for pharmaceutical industry leaders that require advanced API solutions to gain sustainable competitive advantage.
The company is on the same wavelength as its customers–a partner in tune with the results required to best support their needs.
Founded in Israel in 1987, with more than 250 customers in 50 countries, Wavelength produces more than 250 metric tons of commercial APIs every year across a wide range of technologies including injectables, inhalables, highly potent, cytotoxic and controlled substances. Its cGMP-compliant facility is a first-class operation recognised for excellence in safety and environmental stewardship.
Wavelength has achieved an exceptional track record for more than 30 years with all leading global regulatory authorities, including USFDA, EU-EMA, PMDA, TGA, KFDA, ANVISA and COFEPRIS.
The company includes experts in complex chemistry, process development and scale-up, enzymatic reactions, crystalline forms and particle design, spray drying and other bioavailability-enhancing solutions.
Wavelength offers end-to-end customised solutions to meet individual customer requirements, including full-spectrum API CDMO services from pre-clinical grams to multi-ton commercial scale – always with uncompromising consistent quality, regulatory compliance and exceptional customer service.